- Investing Ideas
- /
- Software Healthcare Sector
Software Healthcare Sector
Results
2311
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,311 companies
Tandem Diabetes Care
Market Cap: US$1.5b
Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
TNDM
US$22.98
7D
7.0%
1Y
-48.2%
Andlauer Healthcare Group
Market Cap: CA$2.1b
A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.
AND
CA$53.50
7D
-0.02%
1Y
35.3%
Immunocore Holdings
Market Cap: US$1.5b
A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
IMCR
US$28.40
7D
-6.8%
1Y
-51.8%
Phreesia
Market Cap: US$1.5b
Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
PHR
US$25.62
7D
-0.4%
1Y
19.9%
National HealthCare
Market Cap: US$1.5b
Engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals.
NHC
US$100.54
7D
4.5%
1Y
5.9%
ANI Pharmaceuticals
Market Cap: US$1.5b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$66.30
7D
-9.1%
1Y
-2.6%
Ryman Healthcare
Market Cap: NZ$2.5b
Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.
RYM
NZ$2.42
7D
3.4%
1Y
-34.1%
Regis Healthcare
Market Cap: AU$2.2b
Engages in the provision of residential aged care services in Australia.
REG
AU$7.43
7D
1.9%
1Y
78.6%
Adaptive Biotechnologies
Market Cap: US$1.4b
A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
ADPT
US$9.03
7D
-8.2%
1Y
158.0%
MannKind
Market Cap: US$1.4b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$4.56
7D
-8.8%
1Y
5.6%
Vera Therapeutics
Market Cap: US$1.4b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$21.71
7D
-14.2%
1Y
-47.5%
Mesoblast
Market Cap: AU$2.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.71
7D
-7.6%
1Y
60.1%
Green Thumb Industries
Market Cap: CA$1.9b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.71
7D
-14.0%
1Y
-55.9%
Indivior
Market Cap: UK£1.0b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£8.28
7D
-6.8%
1Y
-42.2%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
agilon health
Market Cap: US$1.3b
Provides healthcare services for seniors through primary care physicians in the communities of the United States.
AGL
US$2.89
7D
-30.5%
1Y
-44.3%
ARS Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$13.44
7D
-7.1%
1Y
53.8%
Liquidia
Market Cap: US$1.3b
A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
LQDA
US$15.26
7D
-3.6%
1Y
26.5%
Heska
Market Cap: US$1.3b
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.
HSKA
US$119.99
7D
0.1%
1Y
39.9%
Neogen
Market Cap: US$1.3b
Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
NEOG
US$5.97
7D
3.8%
1Y
-51.6%
Celldex Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$18.33
7D
-11.3%
1Y
-54.1%
Dyne Therapeutics
Market Cap: US$1.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$11.41
7D
-3.8%
1Y
-56.1%
GRAIL
Market Cap: US$1.3b
A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
GRAL
US$35.20
7D
-1.6%
1Y
n/a
Azenta
Market Cap: US$1.3b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$26.77
7D
-0.7%
1Y
-48.1%
Evolent Health
Market Cap: US$1.2b
Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
EVH
US$9.05
7D
-15.3%
1Y
-63.0%
dentalcorp Holdings
Market Cap: CA$1.7b
Through its subsidiaries, provides health care services by acquiring and partnering with dental practices in Canada.
DNTL
CA$8.81
7D
1.1%
1Y
45.4%
Teladoc Health
Market Cap: US$1.2b
Provides virtual healthcare services worldwide.
TDOC
US$7.11
7D
0.7%
1Y
-40.5%
CVS Group
Market Cap: UK£932.6m
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG
UK£13.00
7D
0.2%
1Y
32.2%
Artivion
Market Cap: US$1.2b
Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
AORT
US$28.91
7D
23.9%
1Y
22.9%
Pediatrix Medical Group
Market Cap: US$1.2b
Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
MD
US$14.53
7D
12.3%
1Y
76.8%
Omnicell
Market Cap: US$1.2b
Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
OMCL
US$25.78
7D
-17.3%
1Y
-14.4%
Ocular Therapeutix
Market Cap: US$1.2b
A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.
OCUL
US$7.06
7D
-19.8%
1Y
24.7%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$24.11
7D
-1.6%
1Y
-42.9%
Innoviva
Market Cap: US$1.2b
Engages in the development and commercialization of pharmaceutical products in the United States and internationally.
INVA
US$18.56
7D
-0.9%
1Y
19.0%
Dynavax Technologies
Market Cap: US$1.2b
A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.
DVAX
US$9.41
7D
-16.9%
1Y
-12.3%
Kestra Medical Technologies
Market Cap: US$1.2b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$22.68
7D
-4.5%
1Y
n/a